The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial.

Gappa M, Gagnon R, Horak F, Cichocka-Jarosz E, Dalgaard T, Hargreaves K, Mikler J, Emeryk A, Hansen KS, Pfaar O

DOI: 10.1111/all.16363
Published: 2025 Mar
Container: Allergy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/all.16363,
  title = {The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial.},
  author = {Gappa M and Gagnon R and Horak F and Cichocka-Jarosz E and Dalgaard T and Hargreaves K and Mikler J and Emeryk A and Hansen KS and Pfaar O},
  year = {2025},
  journal = {Allergy},
  doi = {10.1111/all.16363},
  url = {https://doi.org/10.1111/all.16363}
}

RIS

TY  - JOUR
TI  - The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial.
AU  - Gappa M
AU  - Gagnon R
AU  - Horak F
AU  - Cichocka-Jarosz E
AU  - Dalgaard T
AU  - Hargreaves K
AU  - Mikler J
AU  - Emeryk A
AU  - Hansen KS
AU  - Pfaar O
PY  - 2025
JO  - Allergy
DO  - 10.1111/all.16363
UR  - https://doi.org/10.1111/all.16363
ER  -

APA

M, G., R, G., F, H., E, C., T, D., K, H., J, M., A, E., KS, H., & O, P. (2025). The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial.. Allergy. https://doi.org/10.1111/all.16363

Source records

pubmed · retrieved 2026-09-26T21:28:23.273Z